You are here: Industry Insights > CEPI

News List

CEPI to fund Clover’s Covid-19 vaccine development pharmaceutical-technology
November 06, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has extended its partnership to fund the development of Sichuan Clover Biopharmaceuticals’ protein-based S-Trimer Covid-19 vaccine candidate.
CEPI extends partnership with Clover Biopharma to fund COVID-19 vaccine candidate expresspharma
November 04, 2020
CEPI to fund the development of Clover’s protein-based S-Trimer vaccine candidate through to licensure, including a global pivotal Phase 2/3 efficacy clinical study beginning before the end of 2020.
CEPI Expands Partnership with Clover contractpharma
July 14, 2020
To rapidly advance development and manufacture of COVID-19 vax candidate, invests an additional $66M upfront in Clover’s S-Trimer protein.
CEPI expands Covid-19 vaccine alliance with Clover Biopharmaceuticals pharmaceutical-technology
July 09, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has expanded its collaboration with China-based Sichuan Clover Biopharmaceuticals to speed-up the development and manufacture of Covid-19 vaccine candidate.
UQ, CEPI and CSL Partner on Development and Manufacture of COVID-19 Vax Candidate contractpharma
June 09, 2020
CSL appointed manufacturer for University of Queensland's "molecular clamp" enabled COVID-19 vaccine candidate.
AZ ramps up supply capacity for COVID-19 vaccine pharmatimes
June 08, 2020
AstraZeneca has sealed landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII) to broaden global access to the University of Oxford’s COVID-19 vaccine.
AstraZeneca signs $750m Covid-19 vaccine manufacturing deal pharmaceutical-technology
June 08, 2020
straZeneca has signed a $750m agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi the Vaccine Alliance for the production, procurement and distribution of 300 million doses of the University of Oxford’s Covid-19 vaccine.
CSL teams up with CEPI and UQ for Covid-19 vaccine pharmaceutical-technology
June 08, 2020
Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university’s Covid-19 vaccine.
CEPI invests $384m in Novavax COVID-19 vaccine candidate europeanpharmaceuticalreview
May 13, 2020
CEPI has announced that its funding for the Novavax COVID-19 vaccine candidate will go towards Phase I and Phase II trials as well as manufacturing costs.
CEPI to provide up to $388m for Novavax’s Covid-19 vaccine pharmaceutical-technology
May 13, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has agreed to provide up to $384m in funding to support Novavax in the development and manufacturing of Covid-19 vaccine candidate, NVX-CoV2373.

Previous page 1 2 3 4 5 Next page